Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | HTT | P42858 | 2/20 | 0.35 |
| ▸ | TKT | P29401 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | CCR1 | P32246 | 1/20 | 0.34 |
| ▸ | CCR5 | P51681 | 1/20 | 0.34 |
| ▸ | ATP4A | P20648 | 1/20 | 0.34 |
| ▸ | ATP4B | P51164 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19284141 | 0.80 | ATP4A (0.35) | ALDH1A1ATP4AATP4BMEN1KMT2A | |
| SCHEMBL25786511 | 0.80 | EGLN2 (0.39) | ALDH1A1KDM4EHTTTKTATP4A | |
| SCHEMBL20565709 | 0.80 | KMT2A (0.36) | ALDH1A1KDM4ETKTRAB9ACCR1 | |
| SCHEMBL30034016 | 0.80 | KMT2A (0.36) | ALDH1A1KDM4ETKTRAB9ACCR1 | |
| SCHEMBL32680194 | 0.77 | NNMT (0.41) | TDP1KMT2ACYP1A2 | |
| SCHEMBL14051365 | 0.77 | NNMT (0.41) | TDP1KMT2ACYP1A2 | |
| SCHEMBL24168466 | 0.76 | RXRA (0.34) | HTTTKTL3MBTL1TDP1SMN1; SMN2 | |
| SCHEMBL25786512 | 0.76 | KDM4E (0.39) | KDM4ETKTRAB9ANPC1GAA | |
| SCHEMBL4165768 | 0.76 | KDM4E (0.34) | ALDH1A1KDM4EHTTRAB9AATP4A | |
| SCHEMBL7573152 | 0.73 | CCR1 (0.40) | ALDH1A1KDM4ERAB9ACCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4524146-A1 | MRNA CAP ANALOG AND METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING MRNA, AND KIT | YAMASA CORPORATION (JP) | 2025-03-19 | — | — | EP | disclosed |
| US-12202848-B2 | Phosphoramidite activator | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2025-01-21 | — | — | US | disclosed |
| US-20240166674-A1 | PHOSPHORAMIDITE ACTIVATOR | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2024-05-23 | — | — | US | disclosed |
| CN-114555617-B | Phosphoramidite activators | 富士胶片和光纯药株式会社 | 2024-03-08 | — | — | CN | disclosed |
| EP-4047004-B1 | PHOSPHORAMIDITE ACTIVATOR | FUJIFILM WAKO PURE CHEMICAL CORP (JP) | 2024-03-06 | — | — | EP | disclosed |
| WO-2023219114-A1 | MRNA CAP ANALOG AND METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING MRNA, AND KIT | ヤマサ醤油株式会社 | 2023-11-16 | — | — | WO | disclosed |
| WO-2022255273-A1 | LIGAND-BOUND NUCLEIC ACID COMPLEX | レナセラピューティクス株式会社 | 2022-12-08 | — | — | WO | disclosed |
| EP-4047004-A1 | PHOSPHORAMIDITE ACTIVATOR | FUJIFILM Wako Pure Chemical Corporation (JP) | 2022-08-24 | — | — | EP | disclosed |
| US-20200054630-A1 | BENZAMIDES-CONTAINING COMPOUNDS AND THEIR USE IN THE TREATMENT OF DEPRESSION | MINDIMMUNE THERAPEUTICS, INC. | 2020-02-20 | — | — | US | disclosed |
| US-10238654-B2 | Benzamides-containing compounds and their use in the treatment of epilepsy | MINDIMMUNE THERAPEUTICS, INC. (US) | 2019-03-26 | — | — | US | disclosed |
| EP-2906546-B1 | BENZAMIDES | H LUNDBECK AS (DK) | 2018-01-10 | — | — | EP | disclosed |
| US-20170202836-A1 | Benzamides-Containing Compounds and Their Use in the Treatment of Epilepsy | H. LUNDBECK A/S (DK) | 2017-07-20 | — | — | US | disclosed |
| US-9649308-B2 | Benzamide-containing compounds and their use in the treatment of pain | H. LUNDBECK A/S (DK) | 2017-05-16 | — | — | US | disclosed |
| US-20150283134-A1 | Benzamides | MINDIMMUNE THERAPEUTICS, INC. | 2015-10-08 | — | — | US | disclosed |
| CN-104884445-A | Benzamides | LUNDBECK & CO AS H | 2015-09-02 | — | — | CN | disclosed |
| EP-2906546-A1 | BENZAMIDES | H. Lundbeck A/S (DK) | 2015-08-19 | — | — | EP | disclosed |
| US-9102591-B2 | Benzamides | H. LUNDBECK A/S (DK) | 2015-08-11 | — | — | US | disclosed |
| WO-2014057078-A1 | BENZAMIDES | H. LUNDBECK A/S (DK) | 2014-04-17 | — | — | WO | disclosed |
| US-20140107340-A1 | Benzamides | H. LUNDBECK A/S (DK) | 2014-04-17 | — | — | US | disclosed |
| US-20080108557-A1 | Modified Proteins | NOVO NORDISK HEALTHCARE A/G (CH) | 2008-05-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200054630-A1 | BENZAMIDES-CONTAINING COMPOUNDS AND THEIR USE IN THE TREATMENT OF DEPRESSION | P2RX5, P2RX7, P2RX2 | ALDH1A1 637/4885KDM4E 1502/4885HTT 2050/4885 |
| US-20240166674-A1 | PHOSPHORAMIDITE ACTIVATOR | ITPA, INPP5D, INPP5B | ALDH1A1 3801/4885KDM4E 2521/4885HTT 1740/4885 |
| US-20140107340-A1 | Benzamides | P2RX7, TRPV1, P2RX5 | ALDH1A1 1424/4885KDM4E 2338/4885HTT 3505/4885 |
| US-20080108557-A1 | Modified Proteins | PTMS, DNPEP, STT3A | ALDH1A1 3891/4885KDM4E 3955/4885HTT 2769/4885 |
| US-12202848-B2 | Phosphoramidite activator | ITPA, INPP5D, INPP5B | ALDH1A1 3801/4885KDM4E 2521/4885HTT 1740/4885 |
| US-10238654-B2 | Benzamides-containing compounds and their use in the treatment of epilepsy | P2RX5, P2RX7, P2RX6 | ALDH1A1 767/4885KDM4E 1075/4885HTT 3383/4885 |
| US-20170202836-A1 | Benzamides-Containing Compounds and Their Use in the Treatment of Epilepsy | P2RX5, P2RX7, P2RX6 | ALDH1A1 767/4885KDM4E 1075/4885HTT 3383/4885 |
| US-20150283134-A1 | Benzamides | P2RX7, TRPV1, P2RX5 | ALDH1A1 1424/4885KDM4E 2338/4885HTT 3505/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.